Literature DB >> 26959697

Intravascular Myopericytoma of the Plantar Region: Case Report and Discussion of the Probable Origin From a Cutaneous Vascular Malformation.

Jaime Agustí1, Lucas Peñas, Nuria Bosch.   

Abstract

Myopericytoma is a perivascular myoid neoplasm of skin and soft tissues characterized by numerous thin-walled blood vessels surrounded concentrically by round to spindle myoid tumor cells, which shows α-smooth muscle actin and h-caldesmon coexpression and commonly negativity for desmin. These tumors arise predominantly in extremities of adult patients with benign clinical course. Based on the architectural pattern, there are various histologic variants as classical-solid myopericytoma, hemangiopericytoma-like myopericytoma, angioleiomyoma-like myopericytoma, myofibroma-like myopericytoma, hipocelular fibroma-like myopericytoma, intravascular myopericytoma, cellular immature myopericytoma, and malignant myopericytoma. The authors report a case that fully satisfies the morphological and immunohistochemical criteria for intravascular myopericytoma, which plantar location is not previously described in the literature. In addition, the authors discuss about its possible development from a preexistent cutaneous vascular malformation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26959697     DOI: 10.1097/DAD.0000000000000522

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  3 in total

Review 1.  [Tumor-induced osteomalacia caused by an FGF23-secreting myopericytoma : Case report and literature review].

Authors:  N Muro Bushart; L Tharun; R Oheim; A Paech; J Kiene
Journal:  Orthopade       Date:  2020-01       Impact factor: 1.087

2.  Foot soft tissue myopericytoma: Case-report and review.

Authors:  D Provenzano; S Lo Bianco; M Belfiore; A Buffone; M A Cannizzaro
Journal:  Int J Surg Case Rep       Date:  2017-11-09

3.  Diagnostic dilemma in soft tissue swelling of a finger.

Authors:  Ruchi Nagpal; Arvind Ahuja
Journal:  Med Pharm Rep       Date:  2019-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.